Shergis Johannah L, Wu Lei, Zhang Anthony L, Guo Xinfeng, Lu Chuanjian, Xue Charlie C
a China-Australia International Research Centre for Chinese Medicine, School of Health and Biomedical Sciences, RMIT University , Melbourne , Australia.
b Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, The Second Clinical College, Guangzhou University of Chinese Medicine , Guangzhou , China.
J Asthma. 2016 Aug;53(6):650-9. doi: 10.3109/02770903.2015.1101473. Epub 2016 May 12.
Many people with asthma use herbal medicines to help reduce symptoms and improve asthma control.
To update the systematic review and meta-analysis of randomised controlled trials of herbal medicine for adult asthma.
Nine English and Chinese databases were searched (PubMed, Embase, CINAHL, CENTRAL, AMED, CBM, CNKI, CQVIP, Wanfang).
Herbal medicines combined with routine pharmacotherapies compared with the same pharmacotherapies alone or placebo. Cochrane Risk of Bias Tool and GRADE Summary of Findings tables were used to evaluate methodological quality.
Twenty-nine (29) studies involving 3,001 participants were included. Herbal interventions used multi-ingredients such as licorice root, crow-dipper, astragali, and angelica. Compared with routine pharmacotherapies alone, herbal medicines as add-on therapy improved lung function (FEV1: MD 7.81%, 95% CI 5.79, 9.83, I(2) = 63%; PEFR: MD 65.14 L/min, 95% CI 58.87, 71.41, I(2) = 21%); asthma control (MD 2.47 points, 95% CI 1.64, 3.29, I(2) = 55%); reduced salbutamol usage (MD -1.14 puffs/day, 95% CI -2.20, -0.09, I(2) = 92%); and reduced acute asthma exacerbations over one year (MD -1.20, 95% CI -1.82, -0.58, one study). Compared with placebo plus pharmacotherapies herbal medicines as add-on therapy improved lung function (FEV1: MD 15.83%, 95% CI 13.54, 18.12 and PEFR: MD 55.20 L/min, 95% CI 33.41, 76.99). Other outcomes were not reported in these placebo studies. Included studies were low to moderate quality. Adverse events were rare.
Herbal medicines combined with routine pharmacotherapies improved asthma outcomes greater than pharmacotherapies alone. Included studies did not blind participants therefore more studies that address such weaknesses are warranted.
许多哮喘患者使用草药来帮助减轻症状并改善哮喘控制。
更新关于成人哮喘草药治疗的随机对照试验的系统评价和荟萃分析。
检索了9个英文和中文数据库(PubMed、Embase、CINAHL、CENTRAL、AMED、CBM、CNKI、CQVIP、万方)。
将草药与常规药物疗法联合使用与单独使用相同药物疗法或安慰剂进行比较。使用Cochrane偏倚风险工具和GRADE结果总结表来评估方法学质量。
纳入了29项研究,涉及3001名参与者。草药干预使用了多种成分,如甘草根、地锦草、黄芪和当归。与单独的常规药物疗法相比,草药作为附加疗法可改善肺功能(第一秒用力呼气容积:平均差7.81%,95%置信区间5.79,9.83,I² = 63%;呼气峰值流速:平均差65.14升/分钟,95%置信区间58.87,71.41,I² = 21%);哮喘控制(平均差2.47分,95%置信区间1.64,3.29,I² = 55%);减少沙丁胺醇使用量(平均差-1.14吸/天,95%置信区间-2.20,-0.09,I² = 92%);以及在一年中减少急性哮喘发作(平均差-1.20,95%置信区间-1.82,-0.58,一项研究)。与安慰剂加药物疗法相比,草药作为附加疗法可改善肺功能(第一秒用力呼气容积:平均差15.83%,95%置信区间13.54,18.12;呼气峰值流速:平均差55.20升/分钟,95%置信区间33.41,76.99)。这些安慰剂研究中未报告其他结果。纳入的研究质量低至中等。不良事件很少见。
草药与常规药物疗法联合使用比单独使用药物疗法能更好地改善哮喘结局。纳入的研究未对参与者进行盲法处理,因此需要更多解决此类不足的研究。